Search Results
Oct 16, 2025, 17:24 ET The Inner Circle acknowledges, Richard C. Larson, PhD, as a 2025 Life Achiever
CAMBRIDGE, Mass., Oct. 16, 2025 /PRNewswire/ -- Prominently featured in The Inner Circle, Richard C. Larson, PhD is acknowledged as a 2025 Life Achiever for his contributions to Innovating in Academia, especially Operations Research and Industrial Engineering. As
More news about: The Inner Circle
Oct 16, 2025, 17:02 ET Invetech Wins 2025 Australian Good Design Award Gold for Excellence in Design and Innovation
"This recognition is a reflection of the team's relentless pursuit of excellence," said Damian Verdnik, PhD, Vice President of Diagnostics at Invetech. "It highlights the impact this work has on delivering valuable solutions for our clients."
More news about: Invetech
Oct 16, 2025, 13:12 ET ImageTrend Announces New Medical Advisory Board Members
Jacob Keeperman, MD – GMR Foundation for Research and Education Ashish R. Panchal, MD, PhD, FAEMS – The Ohio State University Wexner Medical Center, Delaware County EMS, and National Registry of EMT Research
More news about: ImageTrend LLC
Oct 16, 2025, 11:04 ET Tagworks Pharmaceuticals anuncia el inicio del ensayo clínico de fase 0/1 para TGW211
ensayo clínico este año marcan un hito importante para Tagworks y validan el potencial de nuestra plataforma Click-to-Release", explicó Marc Robillard, PhD, director científico y cofundador de Tagworks. "A diferencia de los péptidos, los anticuerpos monoclonales radiomarcados evitan las altas dosis de radiación
More news about: Tagworks Pharmaceuticals BV
Oct 16, 2025, 10:39 ET Tagworks Pharmaceuticals annonce l'autorisation du CTA et le début de l'essai clinique de phase 0/1 pour TGW211, un produit radiopharmaceutique pour le traitement des tumeurs HER2+
clinique cette année marquent une étape importante pour Tagworks et valident le potentiel de notre plateforme Click-to-Release », déclare Marc Robillard, PhD, directeur scientifique et cofondateur de Tagworks. « Contrairement aux peptides, les anticorps monoclonaux radiomarqués évitent les doses élevées de
More news about: Tagworks Pharmaceuticals BV
Oct 16, 2025, 09:39 ET Town Hall Ventures Announces $440 Million Fund IV to Advance AI and Healthcare Innovation for Underserved Communities
improve outcomes, and expand access to high-quality care for tens of millions of people underserved by the healthcare system," said Meera Mani, MD, PhD, General Partner of Town Hall Ventures. Investors have recognized the importance of this mission. "The obsession that the Town
More news about: Town Hall Ventures
Oct 16, 2025, 09:33 ET Meet Caravel: Pioneering a New Era of Biotechnology with the First Unified Platform for Protein Discovery and Delivery
animal health sector. Advisors: Kevin Gray, PhD, advises the company on biochemical manufacturing strategy. Oscar Mendoza, Ph.D., and Eve Hanks, PhD, advise the company on animal health strategy. In addition
More news about: Caravel Bio
Oct 16, 2025, 09:00 ET Nanopath Expands Leadership Team to Drive Next Phase of Scientific and Commercial Growth
enthusiasm for Nanopath's clinical impact is unmatched," said Dr. Evantash. Matthew Black, PhD: Chief Scientific OfficerDr. Black, who has led Nanopath's Assay Development Team since 2023, has been promoted to Chief Scientific Officer.
More news about: Nanopath
Oct 16, 2025, 08:30 ET Deconstructing OCD Through the Use of Multiple Operant Behavioral Tasks in Rodents, Upcoming Webinar Hosted by Xtalks
Professor, Department of Pharmacology & Toxicology, University of Toronto; Parisa Moazen, PhD, Scientific Director, Global Scientific Representative of Cognition and Aging, Transpharmation Ltd; and Trevor Robbins, PhD, Professor, Cognitive Neuroscience, University of Cambridge, for the live webinar on Monday,
More news about: Xtalks
Oct 16, 2025, 08:00 ET Eilean Therapeutics Presents Novel, Selective, Brain-Permeable CDK2 Inhibitor for Treatment of CCNE1-Dependent Cancers
clinical study in Q4 2025. "Targeting CCNE1/CDK2-driven cancers remains an urgent unmet medical need," said Nikolay Savchuk, PhD, Chief Operating Officer at Eilean Therapeutics. "Our data demonstrate that this compound achieves an optimal balance of potency, selectivity, and brain
More news about: Eilean Therapeutics
Oct 16, 2025, 08:00 ET Calico Appoints Philip R. Kym, Ph.D., as Head of Drug Discovery
download multimedia:https://www.prnewswire.com/news-releases/calico-appoints-philip-r-kym-phd-as-head-of-drug-discovery-302585608.html
More news about: Calico Life Sciences LLC
Oct 16, 2025, 07:29 ET Winter is Coming: Austin Trail of Lights Tickets ON SALE NOW and Backed with a Weather Guarantee
ticket along with their refund. "The holidays are about creating memories, not stressing over the weather," said Nick Cavanaugh, PhD, CEO of Sensible Weather. "Our Weather Guarantee makes sure that rain or an unexpected Texas snow never gets in the way of enjoying the magic of Austin
More news about: Ticketbud
Oct 16, 2025, 06:12 ET The Galien Foundation Hosts 2025 Patient Summit to Amplify the Patient Voice in Healthcare
Eric Horvitz MD, PhD – Chair, Chief Scientific Officer of Microsoft Grace Cordovano, PhD, BCPA – Founder, Enlightening Results Co-Founder, Unblock Health
More news about: The Galien Foundation
Oct 16, 2025, 05:30 ET QS Arab Region Rankings 2026
Lebanon. Morocco excels in teaching quality, with the most top-10 universities for Staff with PhD. Iraq leads in teaching resources, with three universities in the top 10 for Faculty–Student Ratio.
More news about: QS Quacquarelli Symonds
Oct 16, 2025, 05:30 ET QS Arab Region Rankings 2026
Lebanon. Morocco excels in teaching quality, with the most top-10 universities for Staff with PhD. Iraq leads in teaching resources, with three universities in the top 10 for Faculty–Student Ratio.
More news about: QS Quacquarelli Symonds
Oct 16, 2025, 05:00 ET Peptilogics Raises $78 Million to Advance Zaloganan Into Pivotal Trial
effective therapeutic options alters the commercial landscape that has made antibiotic development difficult," said Peptilogics' CEO Jonathan Steckbeck, PhD. "Developing treatments for these infections allows us to create a new category of surgical therapeutics for patients who currently have to undergo multiple
More news about: Peptilogics
Oct 16, 2025, 01:28 ET HoneyNaps Concludes a Meaningful Participation at World Sleep 2025 -- Global Spotlight on AI Sleep Medicine Technology
these, HoneyNaps USA plans to establish country-specific customer support and product deployment strategies. Taekyoung (Sean) Ha, PhD, President of HoneyNaps USA, stated, "We will begin by following up with the trial applicants we signed up at the exhibition, while simultaneously establishing
More news about: HoneyNaps
Oct 15, 2025, 23:43 ET VTT identifies new plant-based anti-inflammatory and anti-ageing ingredients for sustainable cosmetics
kit - 2025 - VTT Material Bank For more information: Kirsi-Marja Oksman-Caldentey, PhD Senior Advisor, VTT [email protected] +358405522082
More news about: VTT Info
Oct 15, 2025, 19:45 ET Codoxo to Showcase Generative AI-Enabled FWA Solutions Accelerating Fraud Detection at the 2025 NHCAA Annual Training Conference
hitting their limits—manual processes and disconnected systems consume resources that should focus on high-value investigations," said Musheer Ahmed, PhD, Founder and CEO of Codoxo. "At NHCAA, we'll demonstrate how leading health plans are using our GenAI-powered platform to create streamlined, intelligent
More news about: Codoxo
Oct 15, 2025, 17:57 ET TriNetX devient la source de données réelles la plus citée dans les recherches évaluées par des pairs
que les données qu'ils utilisent résisteront à l'examen par des pairs et qu'elles produiront des résultats significatifs », a déclaré Jeffrey Brown, PhD, directeur scientifique de TriNetX. « Le fait que TriNetX soit désormais l'ensemble de données réelles le plus cité reflète non seulement notre échelle
More news about: TriNetX
Oct 15, 2025, 17:55 ET A TriNetX se torna a fonte de dados do mundo real mais citada em pesquisas revisadas por pares
pesquisadores precisam confiar que os dados que usam enfrentarão a revisão por pares e impulsionarão insights significativos", disse Jeffrey Brown, PhD, diretor científico da TriNetX. "O fato de a TriNetX ser agora o conjunto de dados do mundo real mais citado reflete não apenas nossa escala e qualidade,
More news about: TriNetX
Oct 15, 2025, 17:54 ET TriNetX se convierte en la fuente de datos del mundo real más citada en la investigación revisada por pares
investigadores necesitan confianza en que los datos que utilizan resistirán la revisión por pares e impulsarán ideas significativas", dijo Jeffrey Brown, PhD, director científico de TriNetX. "El hecho de que TriNetX sea ahora el conjunto de datos del mundo real más citado refleja no solo nuestra escala y calidad,
More news about: TriNetX
Oct 15, 2025, 17:51 ET TriNetX se convierte en la fuente de datos del mundo real más citada en investigaciones revisadas por pares
investigadores necesitan tener la seguridad de que los datos que utilizan superarán la revisión por pares y generarán información valiosa", afirmó Jeffrey Brown, PhD, director científico de TriNetX. "El hecho de que TriNetX sea ahora el conjunto de datos del mundo real más citado refleja no solo nuestra escala y calidad,
More news about: TriNetX
Oct 15, 2025, 17:15 ET Southwire CEO Rich Stinson Announces Retirement, Upcoming Executive Changes
Ramaswamy holds a BS in Mechanical Engineering from the University of Kerala, an MS in Mechanical Engineering from Auburn University, a PhD in Mechanical Engineering from the University of Pennsylvania and an MBA from the University of Wisconsin. He currently resides in the Chicago area with
More news about: Southwire
Oct 15, 2025, 15:35 ET 16th Annual Sohn San Francisco Investment Conference to Convene Leading Investors and Support Local Nonprofits
Melissa J. Ma, Co-Founder and Managing Partner, Asia Alternatives Jeff Shen, PhD, Managing Director, Co-Chief Investment Officer and Co-Head of Systematic Active Equities, BlackRock Moderated by Pete
More news about: The Sohn Conference Foundation